Nevirapine or Lamivudine plus Stavudine and Indinavir: Examples of 2‐Class versus 3‐Class Regimens for the Treatment of Human Immunodeficiency Virus Type 1-Reference-Cited by-同舟云学术

Nevirapine or Lamivudine plus Stavudine and Indinavir: Examples of 2‐Class versus 3‐Class Regimens for the Treatment of Human Immunodeficiency Virus Type 1

Published:2002-11 Issue:9 Volume:35 Page:1096-1105
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Launay Odile,Gérard Laurence,Morand‐Joubert Laurence,Flandre Philippe,Guiramand‐Hugon Sonia,Joly Véronique,Peytavin Gilles,Certain Agnès,Lévy Claude,Rivet Stéphane,Jacomet Christine,Aboulker Jean‐Pierre,Yéni Patrick,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/35/9/1096/945000/35-9-1096.pdf

Reference34 articles.

1. Antiretroviral Therapy in Adults

2. Delfraissy JF. Tests de resistance aux antiretroviraux. In: Prise en charge therapeutique des personnes infectees par le VIH: recommandations du groupe d'experts. Mise a jour 2000 du rapport 1999. Paris: Flammarion Medecine-Sciences, 2000:17-28.

3. 3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine

4. High‐Dose Nevirapine in Previously Untreated Human Immunodeficiency Virus Type 1‐Infected Persons Does Not Result in Sustained Suppression of Viral Replication

5. Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics of Toxicity, Plasma Trough Concentration and Treatment Outcome with Nevirapine-Containing Regimen in Anti-Retroviral-Naïve HIV-Infected Adults: An Exploratory Study of the TRIANON ANRS 081 Trial;Basic & Clinical Pharmacology & Toxicology;2011-09-06

2. Stratégies de restauration immunitaire chez les patients infectés par le virus de l’immunodéficience humaine;La Revue de Médecine Interne;2011-07

3. Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: Application to HIV dynamics model;Computational Statistics & Data Analysis;2006-12

4. Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy;AIDS;2005-12-02

5. Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapy;Fundamental and Clinical Pharmacology;2005-06